48,453
edits
Line 28: | Line 28: | ||
*Cystic duct lymph node: [not identified/present, measuring ___ cm in greatest dimension]. | *Cystic duct lymph node: [not identified/present, measuring ___ cm in greatest dimension]. | ||
Sections: | |||
*Representive sections of the neck, body and fundus, including the cystic duct lymph node, are submitted in one cassette. | *Representive sections of the neck, body and fundus, including the cystic duct lymph node, are submitted in one cassette. | ||
Notes: | |||
*[[Intestinal metaplasia of the gallbladder]] does ''not'' have to be [[submitted in total]].<ref name=uscap2017_akki>Akki ''et al.'' (2017) "Detecting Incidental Gallbladder Adenocarcinoma: When to Submit the Entire Gallbladder". Available at: [http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016 http://www.abstracts2view.com/uscap17/view.php?nu=USCAP17L_2016]. United States and Canadian Academy of Pathology Annual Meeting. Accessed on: April 9, 2017.</ref> | |||
*High-grade dysplasia should prompt submitting the gallbladder in total, if not cancer is present.<ref name=uscap2017_akki/> | |||
===Protocol notes=== | ===Protocol notes=== |
edits